FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
Key Details
- 1FDA has approved the Targeted Real-Time Early Warning System for sepsis from researchers at Johns Hopkins, commercialized by Bayesian Health.
- 2The AI analyzes electronic health records to identify sepsis earlier than doctors traditionally can—often by 2 to 48 hours.
- 3System deployment in multiple hospitals reduced sepsis mortality rates by 18% and shortened hospital stays.
- 4Sepsis leads to over 250,000 deaths annually in the US and accounts for one in three in-hospital deaths.
- 5FDA clearance enables hospitals to bill Medicare/Medicaid under the New Technology Add-on Payment program.
- 6The solution demonstrates robust clinical AI integration with real-world hospital data for actionable guidance.
Why It Matters
The FDA's clearance of this early sepsis warning system marks a significant milestone for clinical AI adoption, demonstrating real-world impact on patient outcomes. It highlights how machine learning can augment clinical vigilance and potentially become part of standard hospital care, informing future radiology-AI solutions.
Source
EurekAlert
Related News
•EurekAlert
AI-Powered OCT Enables Rapid 'Optical Biopsy' for Early Endometrial Cancer Detection
A team at Washington University has developed a catheter-based 3D OCT system with AI to quickly and noninvasively detect early endometrial cancers.
•EurekAlert
AI Method Protects Sensitive Data in ECGs While Retaining Clinical Value
Researchers developed an AI model (PP-VAE) that safeguards sensitive personal data in electrocardiograms without sacrificing clinical utility.
•EurekAlert
AI Clinical Reasoning in Diagnostics and Digital Fatigue in Healthcare
Recent JMIR features explore large language models in clinical diagnostics and digital fatigue among healthcare professionals.